Results 71 to 80 of about 18,346 (122)

Tear fluid participates in systemic immunity. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban
Wu T   +5 more
europepmc   +1 more source

Ferroptosis and tumor immunity. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban
Tao Q   +6 more
europepmc   +1 more source

[Immune Checkpoints Mediate Tumor Immune Regulation 
through Metabolic Pathways]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi
Du W   +6 more
europepmc   +1 more source

乙型肝炎病毒BCP、PreC和C区基因突变与母婴传播免疫失败的相关性

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2013
【目的】 探讨BCP、PreC和C区基因突变率及突变热点与HBV母婴传播免疫失败的关系。【方法】 选取血清HBsAg阳性且HBV DNA定量>1000U/mL的孕妇,以所分娩的新生儿是否发生免疫失败和孕妇血清HBV DNA定量水平将孕妇分为免疫失败组(19例)和对照1组(免疫成功且HBV-DNA定量≥1.0 × 107 U/mL,48例)、对照2组(免疫成功且HBV-DNA定量<1.0 × 107 U/mL,38例)。对3组孕妇血中HBV进行BCP/PreC/C区基因PCR扩增和测序 ...
doaj  

[IGSF11: A Novel Target for Cancer Immunotherapy]. [PDF]

open access: yesZhongguo Fei Ai Za Zhi
Feng Z   +7 more
europepmc   +1 more source

流感病毒样颗粒疫苗研究进展

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2009
疫苗接种是预防各种类型流行性感冒的理想方式,但流感病毒血清亚型多,变异性强,给流感疫苗的研发带来一定的挑战。病毒样颗粒(VLP) 是含有某种病毒一个或多个结构蛋白的空心颗粒,形态结构上类似完整病毒,具有与完整病毒相似的免疫原性,并通过激活抗原提呈细胞,诱导免疫应答。VLP不含有病毒核酸,不能自主复制,因此无致病性,在疫苗研发中具有广泛的应用前景。现已有H1N1、H3N2、H5N1、H7N1、H5N3及H9N2型流感VLP合成的报道,动物实验证明这些VLP可诱导产生保护性免疫应答?数种二价(多价 ...
doaj  

Home - About - Disclaimer - Privacy